Excimer Laser

SD Healthcare attended a two-day CME-approved laser refractive surgery course held at leading eye hospital Moorfields, to demonstrate the SCHWIND excimer laser. “Our courses for ophthalmic practitioners have been provided at Moorfields for over 25 years. Continued support from the private sector including SD Healthcare is essential in allowing us to run educational courses and to maintain our world-famous reputation as experts in the field,” said Bruce Allan MD, FRCS, consultant ophthalmic surgeon, at Moorfields. “With over half the ophthalmologists practising in the UK, and many more overseas, having received specialist training at Moorfields – we are the go-to place for treatment, teaching and research,” said Dr Allan. The two-day course covering all areas of refractive surgery – from the basics to femtosecond laser flap creation – saw SD Healthcare experts on hand to demonstrate the SCHWIND Amaris 750s excimer laser during the wet lab sessions. www.sdhealthcare.com
Latest Articles
Addressing Postoperative Visual Complications
Managing aberrations after laser refractive surgery requires a multi-layered approach.
3D Printing Helps Transform Ukrainian Eye Care
The country’s ophthalmologists offer valuable experience in treating ocular trauma and prosthesis design.
Winning Essay Says ‘Collective Desire’ Must Drive DEI Implementation
Emerging Microbial Trends That Could Affect Your Practices
A triptych of challenges paints a concerning picture for ophthalmologists across the globe.
Improving Outcomes with Laser-Assisted Surgery
Femtosecond laser offers a multifunctional tool for improving the safety and efficacy of cataract and refractive lens exchange procedures.
Could the Corneal Transplant Pool Increase?
Modifying or discarding major contraindications for keratoplasty could mean more patients have their sight restored.
Matching Premium IOLs to Visual Lifestyles
From monofocal to full-range solutions, each practice needs comprehensive understanding.
Going Dutch on Acanthamoeba Keratitis
A world-first trial suggests a new medication could beat the disease.
Avoiding Intracorneal Ring Segment Complications
Femtosecond lasers are helping improve refractive results with fewer problems.